Plasma thiol status in preeclampsia

被引:54
作者
Raijmakers, MTM
Zusterzeel, PLM
Steegers, EAP
Hectors, MPC
Demacker, PNM
Peters, WHM
机构
[1] Univ Nijmegen St Radboud Hosp, Dept Gastroenterol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen St Radboud Hosp, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen St Radboud Hosp, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1016/S0029-7844(99)00514-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To measure plasma thiol levels in women with normal pregnancies, women with preeclampsia, and nonpregnant controls to define plasma thiol's effect on glutathione homeostasis and pathophysiology of preeclampsia, Methods: Total plasma cysteine, gamma-glutamylcysteine, homocysteine, cysteinylglycine, and glutathione levels were measured in ten nonpregnant women, ten women with normotensive pregnancies, and 20 women with preeclampsia at delivery. Results: Median total plasma levels of all thiols in normotensive pregnant women were significantly lower than in nonpregnant women. Median total plasma cysteine and homocysteine levels in women with preeclampsia were significantly higher compared with pregnant controls (254 versus 190 mu mol/L P <.001; and 13.3 versus 8.4 mu mol/L, P <.02, respectively), whereas glutathione levels were significantly lower in women with preeclampsia compared with those in pregnant controls (5.1 versus 6.3 mu mol/L, P < .05). Conclusion: In women with preeclampsia, homocysteine and cysteine levels, which are lowered in normotensive pregnancy, were comparable to levels in nonpregnant women, whereas glutathione levels were lower. Those results suggest that in women with preeclampsia, glutathione use is higher or its synthesis is disturbed. Therefore, glutathione might affect pathophysiology of preeclampsia. (C) 2000 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:180 / 184
页数:5
相关论文
共 27 条
  • [1] ANDERSSON A, 1992, CLIN CHEM, V38, P1311
  • [2] ANDERSSON A, 1992, EUR J CLIN CHEM CLIN, V30, P377
  • [3] ARRICK BA, 1984, CANCER RES, V44, P4224
  • [4] PLASMA AND RED-CELL VOLUMES DURING PREGNANCY
    CHESLEY, LC
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1972, 112 (03) : 440 - +
  • [5] AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria -: Prevention by antioxidant vitamins
    de la Asunción, JG
    del Olmo, ML
    Sastre, J
    Millán, A
    Pellín, A
    Pallardó, FV
    Viña, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) : 4 - 9
  • [6] Vitamin supplementation reduces blood homocysteine levels - A controlled trial in patients with venous thrombosis and healthy volunteers
    den Heijer, M
    Brouwer, IA
    Bos, GMJ
    Blom, HJ
    van der Put, NMJ
    Spaans, AP
    Rosendaal, FR
    Thomas, CMG
    Haak, HL
    Wijermans, PW
    Gerrits, WBJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (03) : 356 - 361
  • [7] The metabolism of homocysteine: pathways and regulation
    Finkelstein, JD
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (Suppl 2) : S40 - S44
  • [8] MEASUREMENT OF HOMOCYST(E)INE IN THE PREDICTION OF ARTERIOSCLEROSIS
    FORTIN, LJ
    GENEST, J
    [J]. CLINICAL BIOCHEMISTRY, 1995, 28 (02) : 155 - 162
  • [9] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE
    FROSST, P
    BLOM, HJ
    MILOS, R
    GOYETTE, P
    SHEPPARD, CA
    MATTHEWS, RG
    BOERS, GJH
    DENHEIJER, M
    KLUIJTMANS, LAJ
    VANDENHEUVEL, LP
    ROZEN, R
    [J]. NATURE GENETICS, 1995, 10 (01) : 111 - 113
  • [10] Hyperhomocysteinemia: A risk factor for placental abruption or infarction
    GoddijnWessel, TAW
    Wouters, MGAJ
    VanderMolen, EF
    Spuijbroek, MDEH
    SteegersTheunissen, RPM
    Blom, HJ
    Boers, GHJ
    Eskes, TKAB
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 66 (01): : 23 - 29